Categories

Above the Fold

POLICY: More on the realities of the crisis of uninsurance, by Anonymous

There’s been quite a fuss about the recent study showing that bankruptcy is frequently caused by high health care bills, or at least by the inability of those who are sick to return to work and pay off those bills. THCB contributor Anonymous wrote about her tough experience accessing care last November.  Now the bills are due and she finds herself on just that slippery slope. Here’s Anonymous story:

I was seen at the Alta Bates ER twice within a week for the same problem. Both times I received a form for the charity program. No one explained anything to me about two separate billing systems or that the charity program wouldn’t apply to the physician part of the bill. I initially needed help providing the proof required by the charity program. Alta Bates ignored my first letter in this regard, and I went through phone tree, transfer, and wait time hell to get to the right department to help me with the problem. When I eventually ended up with a financial counsellor, who was very helpful. She told me she could use  my prior year bank statements, and the charity care program then covered me 100%. I thought everything was wrapped up at that point.
A couple months later, I started receiving threat letters and calls from a collections agency. I called the financial counsellor and asked why I was being billed after I had been covered by the charity care program. She told me that there was a separate physician’s bill not covered by the charity care program. She also told me I had another outstanding bill from 2001(!) The 2001 bill is from a time when I was covered by insurance: I didn’t find out about that until it went into collections, either. But at that point I called my insurer, Blue Cross, and they took care of it. I haven’t heard about it since. Now Alta Bates expects me to remember my insurance information from 2001 to fix it when they were the ones who made the mistake of only applying my insurance information to one of my bills. I’m just boggled by that. Anyway, the counselor told me she couldn’t help me further at that point, and she gave me no guidance on how to proceed.
I went through phone tree, transfer, and wait time hell again, and I ended up at Berkeley Medical Group. I explained to them that I had qualified for the charity care program, no one had explained the two-bill concept or provided me with any alternate charity forms in the ER, and that I had been unaware that I had an outstanding bill until it had gone into collections. I was given the address of somebody in Washington State to write if I want to dispute the bad debt from 2001.The Berkeley Medical Group representative told me that they have no charity program and the fine print of the third bill warns it would go into collections. She did not seem to get what was wrong with the fact no one in the ER explains the fact there are two separate billing systems or explains steps indigent patients should take beyond giving them the forms for the charity care program. I asked her how I should proceed. She told me I had to deal with the collections agency now, and there was nothing she could do for me. I pointed out that the only thing adding a bad debt to the credit record of a person with no income would do would be to make it even harder for them to recover financially and be insured and/or able to pay such bills in the future. She told me that all I could do was call the collections agency.So, here’s where things stand now. I’m not going to call the collections agency. I went through this with the same agency in 2001 to deal with Alta Bates’ billing mistake, and I know this particular agency, American Capital, has a bad business reputation. I will only be setting myself up for threats and harassment if I call them. One amusing aspect is that the collections agency has been leaving messages on my answering machine: they don’t say who they are, but they give the collections case number and expect me to call them long distance! Anyway, I’m not going to deal with them.
I’m considering filing for bankruptcy. Whether I do that depends on whether I can take care of my student loans at the same time. My student loans might be exempt from a bankruptcy claim because they can always be deferred, but if I can get the loans taken care of that means that bankruptcy for hospital bills has larger ramifications for the U.S. financial system as a whole. I’m sure anyone who has to file bankruptcy for a hospital bill will take care of their other bills while they are at it. The question for me at this point is whether it does more damage to my credit rating to file for bankruptcy or simply ignore the collections agency notices. Which will fall off my credit record faster?  I’m also amazed that Alta Bates has been continuing a practice that’s bound to confuse anyone who comes to their ER. Because of the 2001 billing problem, I know that problems like this have been going on at least that long. Surely I’m not the only person who has brought up that patients aren’t being given all the information in the ER. I’m wondering if there isn’t a Patient’s Bill of Rights violation in there somewhere. Even if there isn’t, Alta Bates and Berkeley Medical  Group end up paying extra administrative costs to hunt down people who were simply confused by their billing system.

This type of foul up is very common.  A friend of mine who was well insured was sent to collections by a local medical center for a bill he’d already paid and was dismayed to find it reported as an unpaid debt recently on his credit report when he wanted to get a mortgage. And I personally just finished getting an unnamed insurance company to pay my final provider bill because they had miscalculated my deductible for surgery I had back last April. The move to more HSAs and forcing more people into dealing with a system that can produce bills from 5-10 seperate providers from one procedure is not exactly going to simplify matters. Horror stories like that of Anonymous’ are going to multiply.

BLOGS AND BLOGGING: Grand Rounds is up

A particularly feisty Grand Rounds is up today hosted by the not-quite-mad libertarians over at Catallarchy. A great job by Trent McBride. One day I’ll be brave enough to host one of these things myself!

BLOGS AND BLOGGING: THCB technologically reborn

So after suffering through Blogger’s growing pains, seeing it acquired by Google and waiting patiently for it to catch up with the rest of the market in blogging software, I’ve given up.  It’s disappointing that, even with all the money of Google behind them, the Blogger gang seemed to be having increasing problems keeping their site up–there were two days last week when I couldn’t post at all.  I also use the service to record headlines for my FierceHealthcare newsletter, and several times they weren’t accessible when I came to write the letter near deadline,which was a little stressful.  Furthermore, getting even basic features like category posts up on the service continues to elude Blogger, and the work-around that I used for topic listing cost lots of time and money.

So today THCB moves over to SixApart’s Typepad service. So far I and my webmaster John have been pretty impressed by the uptime and the customer service.  And although Blogger is free and the version of Typepad I’m using is $15 a month, it was becoming a case that in the evolution of my service, free wasn’t cheap enough! Typepad isn’t perfect yet, but at least they are working on it!

We were planning to wait until next month to move, but last week’s problems at Blogger were so severe that we advanced it over this weekend (and I want to thank John for putting in hours over the holiday weekend to get this done). So this current site isn’t quite done, and you’ll see some improvements soon I hope. Please let me know if you have any comments or suggestions.

The other thing that is a first for THCB is that comments will now be on. Let’s see how that goes!

Finally if you get TCHB via RSS, please add the new RSS address to your reader: it’s http://matthewholt.typepad.com/the_health_care_blog/index.rdf If you use a different aggregator service see the box in the right hand column to select the relevant link.

TECHNOLOGY: Informatics position at Highmark

Those of us who spend too much time whining about why this or that health plan can’t get their IT and customer service together now have a chance to do something about it. Highmark, one of the nation’s biggest and richest Blues plans is looking for a VP of Healthcare Informatics, and via one of their vendors asked me to publicize their search.

Here are some minimal details –the catch of course is that you have to move to Pittsburgh (cue abusive letters about snobby Californians…). You can email me if you want the full description and I can send you on — (and no I’m not getting a cut!).

By the way the first job for the new VP of Informatics should be to fix the careers part of the Highmark web site which is totally fouled up when viewed in Firefox and not a whole lot more helpful (but at least is functional) when viewed with Explorer.

PHARMA: Celebrex can remain on the market

Celebrex_2And to add to yesterday’s post (which Blogger prevented from getting up there till most of you had gone home, so it’s really today’s post) the FDA panel this morning ruled that Celebrex can stay on the market, although they concluded that it did have risks. They are due to rule on Bextra and Vioxx later in the day.

UPDATE: The FDA also said that Bextra and Vioxx can stay too, even though Vioxx has already gone.

PHARMA: The FDA, the new safety board and the Cox-2 debacle–an opportunity seemingly being lost

None of this is quite as timely as it would have been 24 hours ago, but it’s worth giving my take on the new developments at FDA, and with the Cox-2s.

Logo3cThe news is that a new board within the FDA will oversee drug safety, and publicize more about its inner workings reviewing drug safety on the Internet. That’s all very well, although it’s not the announcement of an entirely new Federal agency to review post approval marketing and safety that some people might want. And of course it’s a role that will be subject to the FDA overall. The FDA will be led by an insider, Lester Crawford, who has been there all the while that the sky has been falling. THCB contributor Blunter is not alone in describing his appointment as a cop-out.

But it does appear that the FDA ostrich is lifting its head out of the sand. In today’s testimony on the Cox-2s, internal whistleblower David Graham revealed that he was given permission by Crawford to discuss unpublished studies and to give his full opinion. That marks a big change since his last testimony and it suggests that the FDA higher-ups realize that politically they can’t get away with their stonewalling.

It’s also good news that there are now promises to release more information earlier in the process. Part of the issue with the Cox-2s, particularly with Celebrex, is that the FDA (eventually) found out information about trials that it didn’t release to the public. The most pressing example of this is discussed by John Abramson in the excellent Overdosed America. Pfizer had basically hidden results of a 12 month Celebrex study from the FDA and only initially put forward the 6 month interim data. But while FDA got the new results eventually, it required a Freedom of Information Act request so that the public could discover what the FDA knew.

Now that the Cox-2 cat is out of the bag, there’s more and more bad news:

"A new study has linked pain killers Vioxx, Celebrex and Bextra to increased cardiovascular risk, reinforcing findings of other trials that have already sparked concern over the safety of a popular category of drugs."

It’s not just the FDA and big pharma that comes out of this looking bad. The NEJM which published the original results doesn’t seem to be falling all over itself to eat crow. Abramson called them yesterday a "mouthpiece for the industry". The short comment from Jeff Drazen in the NEJM basically in a most understated way suggests that if just possibly Merck and Pfizer had conducted studies to investigate problems with the Cox-2s rather than new trials to get other indications, we might just have figured out the severity of those problems a little sooner. But nowhere is there a real admission from the NEJM that it either misrepresented the VIGOR results in its peer review process, or allowed itself to get conned by big pharma. In terms of further FDA reform, the slightly more aggressive piece also in NEJM by Psaty and Furberg notes that:

For an approved drug, the FDA currently engages in protracted negotiations with manufacturers rather than mandating manufacturers (1) to change a product label, (2) to conduct patient or physician education, (3) to limit advertising to patients or physicians, (4) to modify approved indications, (5) to restrict use to selected patients, (6) to complete post-marketing studies agreed on at the time of approval, (7) to conduct additional post-marketing studies or trials, and (8) to suspend marketing or immediately withdraw a drug. The FDA has recently claimed to lack adequate authority in these areas. We believe that to protect the health of the public, Congress needs to provide the FDA with the necessary authority and also to create an independent Center for Drug Safety with new authority and funding. Civil penalties should be commensurate with the scale of drug sales. Provisional approval and regular repeated review would provide opportunities to reevaluate risk and benefit. In addition, ongoing congressional oversight of the FDA would afford an important forum for the public discussion of drug safety.

But of course we’re probably not going that far anytime soon with the news out yesterday that the drug safety office will be staying within the FDA, which makes it unlikely to be quite as "independent" as all that.

And we’re never going to get to the rational debate about making more drugs available to more patients with everyone concerned having a real understanding of the potential risks and benefits involved. Which is a big pity because that’s what a grown up responsible FDA and medical system should be doing. I’m not convinced that Vioxx should, in a perfect world, be taken off the market. All drugs have some side effects and while Vioxx and Celebrex clearly shouldn’t be given out like candy, there may be patients where they work well with few side-effects and where they are a big improvement over NSAIDs. Theoretically the clinical trial data should be able to identify those patients, and patients on those products could be monitored for cardio-vascular risk, and taken off them if bad things start to happen.

But because the FDA didn’t do its job in the first place, and because the NEJM looked the other way, and because big pharma’s marketing machine ran roughshod over the minimal checks and balances in the system, we’re now in a mess which will likely see more good drugs not getting to market and the development of an overly-conservative approach to patient safety.

Perhaps integrating the use of drugs fully into the medical care delivery process might be a good place to start, rather than having the use of a prescription as a way for a doctor to get a patient out of their office. But that would require a whole new mind-set.

PHARMA/POLICY: The outsider the FDA needs is the consummate insider, with comment from Blunter

Two days before the latest hearings on Vioxx and Celebrex, with a stand-up Republican Senator all but accusing the FDA management of fraud, Bush names the new head of the FDA. And who gets the gig? None other than the guy who’s been temporarily running it onto the rocks. Crawford, the acting head of the F.D.A. is the new leader. THCB contributor and ex-FDAer Blunter last month suggested that a real outsider was needed to rescue the agency. While he wasn’t expecting Syd Wolfe to get the job (and the NY Times has a big profile on Wolfe today too), you can assume that the appointment of Crawford was not what Blunter was looking for. He writes:

Aaarrggh! The President?s nominee to head the Food and Drug Administration is none other than the current acting head: Lester Crawford. This is a real life Phoenix rising out of the ashes of death, and ashes that he created. With controversy swirling around the FDA and its treatment of and failure to protect whistleblowers, and warnings on Vioxx and other COX-2 inhibitors, and then the Adderall situation, and the surreptitious change in the antidepressant labeling, the odds of such a miserable record were against him retaining his present job, let alone getting a promotion.

Any FDA Commissioner nominee must face a Senate confirmation process. As some of my exile friends from Cuba would say: "We ought to hire a balcony for this one." Look on the FDA Web site and see Crawford’s resume — devoid/scrubbed of any association with regulated industry interests. Those who know Crawford say he was once associated with American Cyanamid and several industry groups and associations. Last time his resume was floated for possible confirmation as FDA Commissioner, the ranking minority member on the committee that handles this nomination, Senator Kennedy (D-MA) telegraphed a "dug in" opposition position, and the nomination did not see the light of day.

What a political donnybrook the President has created for himself. Here will be the person who is presiding over one continuing debacle over drug warnings and safety incidents being put into the spotlight in a public confirmation process. Expect real fireworks here that are likely to doom the nomination and wash over onto the Presidency.

Furthermore, the need for the head of the FDA to be paying attention to business is critical right now, and the need to get a Commissioner in place as quickly as possible is also critical. But in the current controversial context surrounding many FDA decisions, who would think that the situation will get any better with the current FDA head off promoting his nomination on Capitol Hill and elsewhere.

No good can filter through to the FDA or the Bush Administration as a result of this faux pas.

Two things to note here. Without revealing his identity I can tell you that Blunter has strong Republican leanings, and thus you should take his views very seriously. Second he thinks that Crawford won’t make it through the nominating process. I’m not sure I agree. It may surprise you all to know that I am not a Republican, but even with some Republican support for some things that the FDA and the Administration opposes (e.g. reimportation) I’m not sure that the Senate has the guts to turn down any Bush nominee–after all they just confirmed torture-memo man Gonzales for AG.

But this will be an opportunity to drag more FDA laundry out in public — and after all the recent posturing by Leavitt, the appointment is made well before the IOM "reform" (whitewashing?) report that is supposed to fix the FDA’s problems. How this makes the FDA better is beyond me.

TECHNOLOGY: HIMSS press release mania

I’ve always noticed that the first day of HIMSS is the biggest each year for press releases in health care IT. But this year I thought that I’d actually go and cull all of them. So here is all those that appeared before 12 noon EST on Monday. There are quite a few (over 75), and it indicates that, vaporware or not, something is going on in this industry.

Take a moment to peruse the list–obviously I don’t expect you to read them all, but you’ll get a sense of what the IT sector of the health care industry is considering news.  And that includes wireless, EMR and patient records, security issues, and medication safety systems.

Itemfield Charts Growth in Healthcare Application Integration with Recent Wins

Siemens Health IT Innovations Drive Workflow-Enabled Transformation in Healthcare

NEC Solutions America Delivers TouchPass Secure Single Sign-On to Atlantic Health System

MedSeek Launches Professional Services Division to Optimize E-Health Initiatives at Hospitals & Health Systems Nationwide

CodeRyte Expands Computer-Assisted Coding Solutions to New Specialty Areas

Two Healthcare Industry Leaders Select CodeRyte Medical Coding Technology

iAnywhere Database Helps Healthcare Partners Revolutionize Point-of-Care Solutions

Anywhere MD INC. (OTC: ANWM) Has Successfully Secured Its Proprietary Desktop and Handheld Computer Programs Against Software Piracy and Duplication

Axolotl Consultants Lead HIM Departments Into the Information Age

Mercy Health Partners Targets Medication Safety Imperative with McKesson Clinical IT and Automation Solutions

Nation’s Leading Hospitalist Network Provides Epocrates Essentials Mobile Clinical Reference Suite to its Physicians

MedKey to Use SanDisk SD/USB Combo Card in New MedChip Product Line

GE Healthcare Unveils Vision of Digital, Wireless and Paperless Healthcare

MedcomSoft to unveil MCDR – its revolutionary clinical data repository for communities

Digital Angel Corporation Ships Electronic Products to USDA in Connection With Study of Chronic Wasting Disease

ScanSoft Dragon NaturallySpeaking Becomes De-Facto Standard Speech Recognition Solution for Healthcare Industry

ProPath Deploys Sybase Technology to Streamline Laboratory Operations

Sybase Tapped for Clinical Information Systems in Two Top Montreal Health Centres

MCS Health Inc. Announces Its Physician Drug Solution Now Available on Blackberry Wireless Handhelds(TM)

Misys Healthcare Systems Connects Physicians Remotely with Misys CPR’s First Web Browser Release

Lawson Signs Multi-Suite Software and Services Contract with Michigan Cancer Center

Regional Healthcare Provider Completes Lawson Multi-Suite Upgrade

GlobalSCAPE’s Healthcare Security Solution Enhances and Protects Electronic Data Exchange Processes

OptiFlex(TM) Supply Chain Software Added to Omnicell Color Touch Supply Cabinets

Mercy Health Partners Targets Medication Safety Imperative with McKesson Clinical IT and Automation Solutions

McKesson’s CarePoint-RN(TM) Gives Nurses Unparalleled Point-of-Care Solution

Omnicell Rolls Out New vSuite(TM) Service Program at HIMSS,


Eclipsys Unveils its ‘Vision of Health’ by Demonstrating the Connected Enterprise at HIMSS 2005

SpectraLink Unveils New Wi-Fi Handset for Healthcare

Arrow International Announces Dividend Increase for Second Fiscal Quarter

Sentillion Selects CTG as Systems Integration Provider

Sentillion Showcases New Security Enhancements to Flagship Product Suite

Hospira and Bridge Medical Announce Agreement to Develop New Medication Management Solution for Use at the Patient Bedside

GetWellNetwork(TM) Introduces PatientLife:)System(TM) to Help Hospitals Achieve Vision of Patient-Centered Care

Xiotech Announces Expanded PACS Support for Healthcare

StorageTek, Partners Team to Provide Award-Winning Care for Health Industry Information

Picis Named Finalist for Microsoft Healthcare Users Group Annual Award

QCSI Introduces the NEXT Breakthrough… QNXT 3.0 at HIMSS 2005

IDX Expands Healthcare Performance Management Capabilities with New IDX(R) Flowcast(TM) Metrics Manager:

Dynamic Health Strategies Selects Intransa to Provide Low-Maintenance, Flexible Storage Infrastructure

Nortel, Verizon Deliver Healthcare Solutions to Leading Providers

Trusted Healthcare Information Solutions Alliance (THISA) Launches at Annual HIMSS Conference in Dallas

MEDecision Puts Payer-Based Patient Record in Doctors’ Hands

RxHub and Performance Partners Demonstrate an Immediate Impact in Reducing Medication Errors and Saving Costs

Demand for EHR Connectivity in Community Settings Drives Growth of Kryptiq Corp.


A4 Health Systems Unveils New Products at HIMSS

Kryptiq Introduces Disease Management Product Developed for Providers:

etrials Partners With The Cardiovascular Research Foundation

HIMSS Honors Healthlink Executives at Annual Conference

Swedish Medical Center in Seattle Selects Softricity’s Software Virtualization for Major IT Infrastructure Update


Intellitactics Demonstrates Industry Leadership with Intellitactics Security Manager Suite Featuring Foundation Services

InterSystems and Sapient Demo New Virtual Electronic Health Record at HIMSS 2005

Cardinal Health First to Integrate Medication Management Solutions for Hospitals

Boston Medical Center Chooses InterSystems’ Ensemble Universal Integration Platform

           Media Alert for StoredIQ

EMRConsultant.com Demonstrates Physician Matching Proprietary System at Booth 6561 During Healthcare Technology Show

PhDx Systems and Smith & Nephew Sign Agreement

Softmed Systems Announces Mobile Healthcare Documentation Solution

SoftMed Systems Continues to Earn Honors from KLAS Enterprises

Leading Healthcare Organizations Select WholeSecurity to Protect Endpoint Computers

Kodak Announces Aggressive Push Into Healthcare IT

Santa Barbara County Care Data Exchange and CareScience Announce Next Step in Roll-out of Care Data Exchange Solution

MobileAccess Introduces Enhanced Wi-Fi Solution Ideal for Healthcare Providers

Greenwich Hospital, a ‘Top 100 Most-Wired Hospital,’ Deploys American Power Conversion’s InfraStruXure(TM) On-Demand Data Center to Cool Blade Servers

St. Mary’s / Duluth Clinic Health System Selects MobileAccess for Wi-Fi Network

Symbol RFID Systems Will Support Law Enforcement to Reduce Drug Counterfeiting

Artificial Medical Intelligence Introduces EMscribe Dx For Automatic Scanning and Coding of Medical Documents

North Shore-LIJ Health System Partners with Cerner to Optimize its Laboratories

Fresenius Deploys Applix TM1 in Multiple Business Units

Media Alert for StoredIQ

QMed, Inc. Becomes the 1st Disease Management Firm to Successfully Complete Sarbanes-Oxley Audit

DST Technologies to Launch AWD Healthcare Process Management-TM- Platform at HIMSS Conference in Dallas

St. Croix Systems Names New CEO


CHRISTUS Health saves $12 million by standardizing 25,000 employees on Kronos


Metro Health Replaces SeeBeyond Software with InterSystems’ Ensemble Universal Integration Platform


CareGroup Goes Live with Web-based Electronic Health Record Built on InterSystems’ CACHE Post-relational Database

Novell Helps Healthcare Providers Organize, Secure Patient Information

BLOGS/TECHNOLOGY: HIMSS staying in the 20th century

Today is the first day of the annual HIMSS conference. I should be there, as it’s the main meeting and greeting place for all health care IT. In the past I’ve been there because my company (either a consulting firm or an IT vendor) paid my way. More recently if I’m not going in a paid capacity to work for a client, I’ve been going to conferences as a combined blogger and editor of Fiercehealthcare. Several conferences have let me in wearing that hat as a Press person. And if I’m not being paid to be there, and I’m reporting on the conference on my blog (as I did with this one on HIT in San Francisco) I don’t see why I can’t get a Press Credential.

But that’s not good enough for HIMSS. They told me that they’d never had a blogger request before, and that as I wasn’t a full-time employee of a mainstream media publication, I couldn’t get a press pass. Well actually they said they would consider it and get back to me, but of course they never did. Apparently they wanted people who would be independent. I did point out that as a solo blogger not working for anyone at all I was a damn site more independent that a typical trade press journalist. But perhaps independence is not what they really want…

The amusing thing is that the people dealing with this were not HIMSS themselves, but their PR company. How having me write a pissy post like this rather than blogging live from the conference for 4 days improves the show’s PR is beyond me. But apparently that’s what they wanted.

assetto corsa mods